Molecular subclassification of kidney tumors and the discovery of new diagnostic markers

Oncogene
Masayuki TakahashiBin Tean Teh

Abstract

We analysed the expression profiles of 70 kidney tumors of different histological subtypes to determine if these subgroups can be distinguished by their gene expression profiles, and to gain insights into the molecular mechanisms underlying each subtype. In all, 39 clear cell renal cell carcinomas (RCC), seven primary and one metastatic papillary RCC, six granular RCC from old classification, five chromophobe RCC, five sarcomatoid RCC, two oncocytomas, three transitional cell carcinomas (TCC) of the renal pelvis and five Wilms' tumors were compared with noncancerous kidney tissues using microarrays containing 19,968 cDNAs. Based on global gene clustering of 3560 selected cDNAs, we found distinct molecular signatures in clear cell, papillary, chromophobe RCC/oncocytoma, TCC and Wilms' subtypes. The close clustering in each of these subtypes points to different tumorigenic pathways as reflected by their histological characteristics. In the clear cell RCC clustering, two subgroups emerged that correlated with clinical outcomes, confirming the potential use of gene expression signatures as a predictor of survival. In the so-called granular cell RCC (terminology for a subtype that is no longer preferred), none of the six cases clust...Continue Reading

References

Feb 1, 1992·Acta Neurologica Scandinavica·D I TemplerM Gorton
Jul 22, 1991·Biochimica Et Biophysica Acta·W F BrechueT H Maren
Mar 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·S E LewisR E Tashian
Dec 1, 1996·Genes, Chromosomes & Cancer·J C PrestiF M Waldman
Apr 29, 1998·The Journal of Clinical Investigation·L W LaiY H Lien
Dec 9, 1998·Proceedings of the National Academy of Sciences of the United States of America·M B EisenD Botstein
May 11, 1999·JAMA : the Journal of the American Medical Association·W H ChowJ F Fraumeni
Jun 1, 1999·Methods in Enzymology·M B Eisen, P O Brown
Sep 21, 2000·BioTechniques·P HegdeJ Quackenbush
Feb 24, 2001·The New England Journal of Medicine·I HedenfalkG Sauter
Aug 9, 2001·Proceedings of the National Academy of Sciences of the United States of America·M TakahashiB T Teh
Oct 31, 2001·The American Journal of Surgical Pathology·Z JiangG R Fanger
Apr 3, 2002·JAMA : the Journal of the American Medical Association·Mark A RubinArul M Chinnaiyan
May 1, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Robert J MotzerVictor Reuter
Jun 21, 2002·The New England Journal of Medicine·Andreas RosenwaldUNKNOWN Lymphoma/Leukemia Molecular Profiling Project

❮ Previous
Next ❯

Citations

Apr 27, 2012·Current Oncology Reports·Leslie J FarberBin Tean Teh
Mar 28, 2008·Current Urology Reports·Jon Jones, Allan J Pantuck
Dec 3, 2008·Pathology Oncology Research : POR·Yan LiuGuancheng Li
Apr 29, 2005·The Journal of Molecular Diagnostics : JMD·Audrey N SchuetzAndrew N Young
Nov 6, 2004·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Tao ShiSteve Horvath
Jan 21, 2006·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Semra OlgacVictor E Reuter
Feb 14, 2006·Nature Clinical Practice. Urology·Alessandro Volpe, Michael A S Jewett
Apr 30, 2013·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J Bellmunt, J Dutcher
Nov 15, 2012·Journal of the National Cancer Institute·Hisashi HasumiW Marston Linehan
Jan 7, 2004·The American Journal of Surgical Pathology·Maria S TretiakovaXiming J Yang
Jul 15, 2004·The American Journal of Surgical Pathology·Kurt T PattonXiming J Yang
Oct 15, 2005·The American Journal of Surgical Pathology·Adrian GologanRajiv Dhir
Sep 7, 2007·Pathology International·Hironori IshizakiMasamichi Kojiro
May 11, 2005·Kidney International·Mingyu LiangJennifer L Pietrusz
Jan 17, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Thomas J GiordanoGary Hammer
Nov 1, 2009·Therapeutic Advances in Medical Oncology·Tanya B DorffDavid I Quinn
Apr 28, 2006·BMC Cancer·Dmitry ZubakovGyula Kovacs
Nov 20, 2009·BMC Clinical Pathology·Ariel A WilliamsJames D Brooks
Feb 18, 2005·American Journal of Clinical Pathology·Shang-Tian ChuangXiming J Yang
Jun 7, 2006·American Journal of Clinical Pathology·Brian P AdleyXiming J Yang
Dec 4, 2009·Indian Journal of Urology : IJU : Journal of the Urological Society of India·John S LamAlberto Breda
Apr 19, 2011·Biomarker Insights·Zhongfa ZhangXiming J Yang
Jan 11, 2012·Archives of Pathology & Laboratory Medicine·Laurie J EisengartXiming J Yang
Dec 25, 2007·Advances in Anatomic Pathology·Andrew N YoungMahul B Amin
Feb 16, 2016·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·Maj RabjergNiels Marcussen

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2022 Meta ULC. All rights reserved